Download PDF
Radiologie up2date 2024; 24(04): 325-340
DOI: 10.1055/a-2339-8490
Pulmonale und kardiovaskuläre Radiologie

Differenzialdiagnose der linksventrikulären Hypertrophie

Differential diagnosis of left ventricular hypertrophy
Sebastian Ley∗
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Von einer linksventrikulären Hypertrophie (LVH) spricht man, wenn die Muskelmasse des linken Ventrikels vergrößert ist. Diese Veränderung tritt bei verschiedenen Ursachen auf, die zu einer Druck- oder Volumenbelastung des linken Ventrikels führen. Zudem gehen auch (infiltrative) Kardiomyopathien mit einer linksventrikulären Wandverdickung einher. Die häufigsten Ursachen einer LVH werden im Folgenden behandelt.
Kernaussagen

  • Eine linksventrikuläre Hypertrophie (LVH) kommt am häufigsten bei einer Hypertonie vor.

  • Ein EKG kann Hinweise auf eine LVH liefern, hat aber eine geringe Sensitivität.

  • Bildgebende Verfahren wie Echokardiografie und MRT sind die wesentlichen diagnostischen Verfahren in der Abklärung und Differenzierung der Ursachen.

  • Die Wanddicke kann und sollte mit jeder Bildgebung des Herzens bestimmt werden. Allerdings sind die absoluten Messwerte der verschiedenen Verfahren nicht übertragbar.

Schlüsselwörter

linksventrikuläre Hypertrophie - hypertrophe Kardiomyopathie - Sportlerherz - Amyloidose

Keywords

left ventricular hypertrophy - hypertrophic cardiomyopathy - athletic heart syndrome - amyloidosis


Publication History

Article published online:
06 December 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Moura B, Aimo A, Al-Mohammad A. et al. Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2023; 25: 1493-1506
    CrossrefPubMedSearch in Google Scholar
  • 2 Elliott PM, Anastasakis A, Borger MA. Authors/Task Force members. et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-2779
    CrossrefPubMedSearch in Google Scholar
  • 3 Bornstein AB, Rao SS, Marwaha K. Left Ventricular Hypertrophy. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023
    Search in Google Scholar
  • 4 Lazzeroni D, Rimoldi O, Camici PG. From Left Ventricular Hypertrophy to Dysfunction and Failure. Circ J 2016; 80: 555-564
    CrossrefPubMedSearch in Google Scholar
  • 5 Sayin BY, Oto A. Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options. Cardiol Ther 2022; 11: 203-230
    CrossrefPubMedSearch in Google Scholar
  • 6 Cuspidi C, Sala C, Negri F. et al. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens 2012; 26: 343-349
    CrossrefPubMedSearch in Google Scholar
  • 7 Hancock EW, Deal BJ, Mirvis DM. et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 992-1002
    CrossrefPubMedSearch in Google Scholar
  • 8 Eber M, Lichtenauer M. Die Linksherzhypertrophie im EKG. Accessed July 16, 2024 at: https://www.universimed.com/de/article/kardiologie-gefaessmedizin/die-linksherzhypertrophie-im-ekg-2099644
    PubMed
  • 9 Bacharova L, Estes EH. Left Ventricular Hypertrophy by the Surface ECG. J Electrocardiol 2017; 50: 906-908
    CrossrefPubMedSearch in Google Scholar
  • 10 Marwick TH, Gillebert TC, Aurigemma G. et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)†. Eur Heart J Cardiovasc Imaging 2015; 16: 577-605
    CrossrefPubMedSearch in Google Scholar
  • 11 Lang RM, Bierig M, Devereux RB. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463
    CrossrefPubMedSearch in Google Scholar
  • 12 Muraru D, Cucchini U, Mihaila S. et al. Left ventricular myocardial strain by three-dimensional speckle-tracking echocardiography in healthy subjects: reference values and analysis of their physiologic and technical determinants. J Am Soc Echocardiogr 2014; 27: 858-871.e1
    CrossrefPubMedSearch in Google Scholar
  • 13 Mizukoshi K, Takeuchi M, Nagata Y. et al. Normal Values of Left Ventricular Mass Index Assessed by Transthoracic Three-Dimensional Echocardiography. J Am Soc Echocardiogr 2016; 29: 51-61
    CrossrefPubMedSearch in Google Scholar
  • 14 Dichtl W. Echokardiographie in der Abklärung der arteriellen Hypertonie. J Hyperton 2016; 20: 94-97
    PubMedSearch in Google Scholar
  • 15 Barbieri A, Bursi F, Mantovani F. et al. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging 2012; 13: 109-117
    CrossrefPubMedSearch in Google Scholar
  • 16 Walpot J, Juneau D, Massalha S. et al. Left Ventricular Mid-Diastolic Wall Thickness: Normal Values for Coronary CT Angiography. Radiol Cardiothorac Imaging 2019; 1: e190034
    CrossrefPubMedSearch in Google Scholar
  • 17 Kara B, Nayman A, Guler I. et al. Quantitative Assessment of Left Ventricular Function and Myocardial Mass: A Comparison of Coronary CT Angiography with Cardiac MRI and Echocardiography. Pol J Radiol 2016; 81: 95-102
    CrossrefPubMedSearch in Google Scholar
  • 18 Grajewski KG, Stojanovska J, Ibrahim EH. et al. Left Ventricular Hypertrophy: Evaluation With Cardiac MRI. Curr Probl Diagn Radiol 2020; 49: 460-475
    CrossrefPubMedSearch in Google Scholar
  • 19 Burrage MK, Ferreira VM. Cardiovascular Magnetic Resonance for the Differentiation of Left Ventricular Hypertrophy. Curr Heart Fail Rep 2020; 17: 192-204
    CrossrefPubMedSearch in Google Scholar
  • 20 Alkema M, Spitzer E, Soliman OI. et al. Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review. J Cardiovasc Ultrasound 2016; 24: 257-267
    CrossrefPubMedSearch in Google Scholar
  • 21 Nemtsova V, Burkard T, Vischer AS. Hypertensive Heart Disease: A Narrative Review Series-Part 2: Macrostructural and Functional Abnormalities. J Clin Med 2023; 12
    CrossrefPubMedSearch in Google Scholar
  • 22 Barbieri A, Albini A, Maisano A. et al. Clinical Value of Complex Echocardiographic Left Ventricular Hypertrophy Classification Based on Concentricity, Mass, and Volume Quantification. Front Cardiovasc Med 2021; 8: 667984
    CrossrefPubMedSearch in Google Scholar
  • 23 Tanaka H. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr 2021; 19: 71-79
    CrossrefPubMedSearch in Google Scholar
  • 24 Chambers J. The left ventricle in aortic stenosis: evidence for the use of ACE inhibitors. Heart 2006; 92: 420-423
    CrossrefPubMedSearch in Google Scholar
  • 25 Rader F, Sachdev E, Arsanjani R. et al. Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications. Am J Med 2015; 128: 344-352
    CrossrefPubMedSearch in Google Scholar
  • 26 Lovic D, Narayan P, Pittaras A. et al. Left ventricular hypertrophy in athletes and hypertensive patients. J Clin Hypertens (Greenwich) 2017; 19: 413-417
    CrossrefPubMedSearch in Google Scholar
  • 27 Junho CVC, Frisch J, Soppert J. et al. Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology. Clin Kidney J 2023; 16: 1786-1803
    CrossrefPubMedSearch in Google Scholar
  • 28 Slany J. Kardiorenale Syndrome. J Hyperton 2011; 15: 20-23
    PubMedSearch in Google Scholar
  • 29 Arbelo E, Protonotarios A, Gimeno JR. et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44: 3503-3626
    CrossrefPubMedSearch in Google Scholar
  • 30 Lousada I, Comenzo RL, Landau H. et al. Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium. Adv Ther 2015; 32: 920-928
    CrossrefPubMedSearch in Google Scholar
  • 31 Yilmaz A, Bauersachs J, Kindermann I. et al. Diagnostik und Therapie der kardialen Amyloidose. Kardiologe 2019; 13: 264-291
    CrossrefPubMedSearch in Google Scholar
  • 32 Linhart A, Kampmann C, Zamorano JL. et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 2007; 28: 1228-1235
    CrossrefPubMedSearch in Google Scholar
  • 33 Hoffmann B, Mayatepek E. Fabry disease-often seen, rarely diagnosed. Dtsch Arztebl Int 2009; 106: 440-447
    CrossrefPubMedSearch in Google Scholar
  • 34 Thompson RB, Chow K, Khan A. et al. T1mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging 2013; 6: 637-645
    CrossrefPubMedSearch in Google Scholar